muse 250 mikrogramm
viatris healthcare gmbh (8009064) - alprostadil - stäbchen zur anwendung in der harnröhre - teil 1 - stäbchen zur anwendung in der harnröhre; alprostadil (22146) 0,25 milligramm
teveten plus hct 600 mg/12,5 mg
mylan healthcare gmbh (8009064) - eprosartanmesilat; hydrochlorothiazid - filmtablette - eprosartanmesilat (27635) 735,8 milligramm; hydrochlorothiazid (00512) 12,5 milligramm
teveten plus hct 600 mg/12,5 mg
mylan healthcare gmbh (8009064) - eprosartanmesilat; hydrochlorothiazid - filmtablette - eprosartanmesilat (27635) 735,8 milligramm; hydrochlorothiazid (00512) 12,5 milligramm
telmisartan fair-med healthcare 20mg tabletten
evertogen life sciences limited (8167656) - telmisartan - tablette - telmisartan (26917) 20 milligramm
urivesc 60 mg retardkapseln
viatris healthcare gmbh (8009064) - trospiumchlorid - hartkapsel, retardiert - teil 1 - hartkapsel, retardiert; trospiumchlorid (07051) 60 milligramm
klacid pro
viatris healthcare gmbh (8009064) - clarithromycin - filmtablette - teil 1 - filmtablette; clarithromycin (23929) 250 milligramm
imatinib koanaa
koanaa healthcare gmbh - imatinib mesilate - leukemia, myelogenous, chronic, bcr-abl positive; precursor cell lymphoblastic leukemia-lymphoma; myelodysplastic-myeloproliferative diseases; hypereosinophilic syndrome; dermatofibrosarcoma; gastrointestinal stromal tumors - antineoplastische mittel - imatinib koanaa is indicated for the treatment ofadult and paediatric patients with newly diagnosed philadelphia chromosome (bcr-abl) positive (ph+) chronic myeloid leukaemia (cml) for whom bone marrow transplantation is not considered as the first line of treatment. adult and paediatric patients with ph+ cml in chronic phase after failure of interferon-alpha therapy, or in accelerated phase or blast crisis. adult and paediatric patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) integrated with chemotherapy. adult patients with relapsed or refractory ph+ all as monotherapy. adult patients with myelodysplastic/myeloproliferative diseases (mds/mpd) associated with platelet-derived growth factor receptor (pdgfr) gene re-arrangements. adult patients with advanced hypereosinophilic syndrome (hes) and/or chronic eosinophilic leukaemia (cel) with fip1l1-pdgfrα rearrangement. the effect of imatinib on the outcome of bone marrow transplantation has not been determined. imatinib koanaa is indicated forthe treatment of adult patients with kit (cd 117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (gist). the adjuvant treatment of adult patients who are at significant risk of relapse following resection of kit (cd117)-positive gist. patienten, die einen niedrigen oder sehr niedrigen rückfallrisiko sollten nicht erhalten eine adjuvante behandlung. the treatment of adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery. in adult and paediatric patients, the effectiveness of imatinib is based on overall haematological and cytogenetic response rates and progression-free survival in cml, on haematological and cytogenetic response rates in ph+ all, mds/mpd, on haematological response rates in hes/cel and on objective response rates in adult patients with unresectable and/or metastatic gist and dfsp and on recurrence-free survival in adjuvant gist. the experience with imatinib in patients with mds/mpd associated with pdgfr gene re-arrangements is very limited (see section 5. außer bei patienten mit neu diagnostiziertem chronischen phase der cml gibt es keine kontrollierten studien zeigen einen klinischen nutzen oder erhöhte überlebenschancen für diese krankheiten.
osa gel dentaire aux plantes avec propolis gel pour application sur les gencives
verfora sa - menthae piperitae aetheroleum, matricariae aetheroleum, salviae lavandulifoliae aetheroleum, caryophylli aetheroleum, propolis farbstoff - gel pour application sur les gencives - menthae piperitae aetheroleum 1 mg, matricariae aetheroleum 1 mg, salviae lavandulifoliae aetheroleum 1 mg, caryophylli aetheroleum 1 mg, propolis tinctura 25 mg, macrogolglyceroli hydroxystearas 25 mg, hydroxyethylcellulosum, carmellosum natricum, ethanolum 96 per centum 12.5 mg, aqua purificata, xylitolum, saccharinum natricum, e 210 2 mg, ad gelatum pro 1 g. - réduit les inflammations des gencives pendant toute la dentition - synthetika
suretin 0,1 % gel
allergan gmbh - tazaroten - gel - tazaroten 1.mg
suretin 0,05 % gel
allergan gmbh - tazaroten - gel - tazaroten 0.5mg